Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gamma-aminobutyric acid + acetaminophen + codeine
- Development stage
- Approved
- Lead developer
- Physician Therapeutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Gamma-aminobutyric acid + acetaminophen + codeine** is a fixed combination/co-pack product corresponding to Physician Therapeutics' **Theracodeine-300**, which combines acetaminophen 300 mg plus codeine 30 mg tablets with the medical food Theramine, an amino-acid blend containing gamma-aminobutyric acid. The pharmacologically active drug components provide analgesia through central cyclooxygenase-related pain pathway modulation by acetaminophen and mu-opioid receptor agonism by codeine, while gamma-aminobutyric acid is included in the accompanying medical food component to support GABAergic pain-modulatory pathways. The product is used for the dietary management of pain and inflammation and for relief of mild to moderately severe pain. It is best understood as a combination product linking a pharmaceutical analgesic pair with a nutritional medical food component.
- Brand names
- Theracodeine-300Theracodeine300Theracodeine 300
- Other names
- gamma-aminobutyric acid + acetaminophen + codeineTheramine + acetaminophen + codeinecodeine + acetaminophen + Theramine
02
Targets
GABRR (GABA-A receptor subunit rho)GABA-B (Gamma-aminobutyric acid receptor type B)COXMOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)
Beyond the preview
Go deeper on gamma-aminobutyric acid + acetaminophen + codeine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gamma-aminobutyric acid + acetaminophen + codeine.